eli lilly tirzepatide FDA approves tirzepatide, Lilly's new type 2 diabetes drug, and the company shares an estimated price Eli Lilly weight loss drug

Mechanism of Action Pancreas: Increases glucose-dependent insulin secretion, decreases glucagon Brain: Enhances satiety Stomach: Slows gastric emptying Main Indications Type 2 diabetes mellitus Obesity/weight management Cardiovascular risk reduction Common Drugs Exenatide Liraglutide Semaglutide Dulaglutide Tirzepatide (dual GIP/GLP-1 agonist) Key Benefits Significant weight loss Low hypoglycemia risk Cardiovascular protection Major Side Effects Nausea/vomiting (most common) Pancreatitis (rare) Thyroid C-cell tumors (boxed warning) Contraindications Multiple Endocrine Neoplasia type 2 (MEN2) Personal/family history of medullary thyroid carcinoma #Pharmaceuticals #GLP1 #Diabetes #Obesity #Healthcare #Biotech #ClinicalResearch #Endocrinology #MedicalAffairs GLP-1 Analogues: Mechanism, Indications, and Side Effects GLP-1 Analogues : Definition Synthetic versions of the natural hormone GLP-1 (glucagon-like peptide-1) that are resistant to DPP-4 breakdown, providing longer-lasting effects

CMS defines an EA plan as coverage that includes the standard prescription coverage as well as supplemental benefits

TucciPBoveMSikoraVDimonteSMorgeseMGSchiavoneSet al

doi: 10.1016/j.cger.2014.08.019

Novo just admitted it

Patient B, who skipped exercise and slept five hours, may peak at 175 mg/dL at the 60-minute mark and still sit at 145 mg/dL at the 2-hour mark